Calonia, Shia Lilly .
HRN: 26-60-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
CEFTRIAXONE 1G (VIAL)
09/26/2025
10/03/2025
IV
350mg
Q12
Tbi, Mild
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines